FLI1 Expression is Correlated with Breast Cancer Cellular Growth, Migration, and Invasion and Altered Gene Expression
暂无分享,去创建一个
V. Findlay | P. Watson | D. Watson | R. Wilson | Robert C. Wilson | Victoria J. Findlay | Paul E. Anderson | T. Rumboldt | Melissa N. Scheiber | Connor Stanley
[1] Paul E. Anderson,et al. Predictive modeling of lung cancer recurrence using alternative splicing events versus differential expression data , 2014, 2014 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology.
[2] Mark Stitt,et al. RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics , 2012, Nucleic Acids Res..
[3] T. Kaisho,et al. The Ets Transcription Factor Spi-B Is Essential for the Differentiation of Intestinal Microfold (M) Cells , 2012, Nature Immunology.
[4] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[5] Johan Staaf,et al. GOBO: Gene Expression-Based Outcome for Breast Cancer Online , 2011, PloS one.
[6] David P Turner,et al. Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. , 2011, Genes & cancer.
[7] Massimo Cristofanilli,et al. Molecular mechanisms of metastasis in breast cancer—clinical applications , 2010, Nature Reviews Clinical Oncology.
[8] Y. Asano,et al. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. , 2010, Journal of dermatological science.
[9] A. Nekrutenko,et al. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.
[10] S. Salzberg,et al. Transcript assembly and abundance estimation from RNA-Seq reveals thousands of new transcripts and switching among isoforms , 2010, Nature biotechnology.
[11] D. Watson,et al. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. , 2010, The American journal of pathology.
[12] David P Turner,et al. Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression* , 2010, The Journal of Biological Chemistry.
[13] D. Watson,et al. Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin , 2008, Molecular and Cellular Biology.
[14] Dennis B. Troup,et al. NCBI GEO: archive for high-throughput functional genomic data , 2008, Nucleic Acids Res..
[15] David P Turner,et al. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. , 2008, Cancer research.
[16] V. Findlay,et al. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. , 2008, Molecular biology of the cell.
[17] R. Hill,et al. p53 binding to the p21 promoter is dependent on the nature of DNA damage , 2008, Cell cycle.
[18] W. Jiang,et al. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. , 2008, Current cancer drug targets.
[19] J. Hamada,et al. Functional roles of Fli‐1, a member of the Ets family of transcription factors, in human breast malignancy , 2007, Cancer science.
[20] J. Rosen,et al. Modelling breast cancer: one size does not fit all , 2007, Nature Reviews Cancer.
[21] B. Rubino,et al. The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.
[22] M. Bhasin,et al. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. , 2007, Cancer research.
[23] David P Turner,et al. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. , 2007, Cancer research.
[24] Jin He,et al. Profile of Ets gene expression in human breast carcinoma , 2007, Cancer biology & therapy.
[25] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[26] M. Markiewicz,et al. Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program* , 2006, Journal of Biological Chemistry.
[27] M. Duffy,et al. Ets2 transcription factor in normal and neoplastic human breast tissue. , 2006, European journal of cancer.
[28] Shridar Ganesan,et al. X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.
[29] A. Seth,et al. ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.
[30] D. Cervi,et al. Direct transcriptional regulation of MDM2 by Fli-1 , 2005, Oncogene.
[31] D. Watson,et al. Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis* , 2004, Journal of Biological Chemistry.
[32] F. Révillion,et al. Prognostic Value of ERM Gene Expression in Human Primary Breast Cancers , 2004, Clinical Cancer Research.
[33] M. Duffy,et al. Overexpression of the Ets-1 transcription factor in human breast cancer , 2004, British Journal of Cancer.
[34] Wei Wang,et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. , 2004, Cancer cell.
[35] David Botstein,et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.
[36] C. Hauser,et al. Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors* , 2004, Journal of Biological Chemistry.
[37] V. Sementchenko,et al. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. , 2003, Cancer research.
[38] D. Watson,et al. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. , 2003, The American journal of pathology.
[39] P. Jackers,et al. Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[40] Hiroshi Kawada,et al. Defective Megakaryopoiesis and Abnormal Erythroid Development inFli-1 Gene-Targeted Mice , 2001, International journal of hematology.
[41] W. Folk,et al. Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers. , 2001, European journal of cancer.
[42] Y. Ben-David,et al. The role of Fli-1 in normal cell function and malignant transformation , 2000, Oncogene.
[43] D. Watson,et al. Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor , 2000, Molecular and Cellular Biology.
[44] R Favier,et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. , 2000, Immunity.
[45] A. Tamir,et al. Fli-1, an Ets-Related Transcription Factor, Regulates Erythropoietin-Induced Erythroid Proliferation and Differentiation: Evidence for Direct Transcriptional Repression of the Rb Gene during Differentiation , 1999, Molecular and Cellular Biology.
[46] K. Chew,et al. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer , 1997, Oncogene.
[47] Wen-Lin Kuo,et al. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis , 1997, Oncogene.
[48] N. Bhat,et al. Generation and characterization of monoclonal antibodies against the ERGB/FLI-1 transcription factor. , 1995, Hybridoma.
[49] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[50] A. Bernstein,et al. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[52] K. Murphy,et al. Role for SpiC in the development of red pulp macrophages and splenic iron homeostasis , 2008 .
[53] Bongsoo Park,et al. BMC Genomics , 2007 .